Adquisición del medicamento BREYANZI 1,1-70 x 10E6 Células/ML dispersión para perfusión (Lisocabtagen Maraleucel), para el Servicio de Farmacia del Hospital Universitario Ramón y Cajal.
TED · 431556-2026Award noticeawardedNo deadline given
Value
Estimated€2,823,840 · 2,823,840 EUR
Awarded€2,823,840 · 2,823,840 EUR
WinnerBRISTOL MYERS SQUIBB S.A.U.
Who already wins at this buyer
Firms with recorded awards from HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| JANSSEN CILAG S.A | 3 | €2,351,724 | 2026-07-30 |
| ROCHE FARMA SAU | 2 | €3,678,270 | 2026-07-07 |
| VERTEX PHARMACEUTICALS SPAIN, S.L. | 1 | €1,080,664 | 2026-06-29 |
| SANOFI-AVENTIS S.A | 1 | €893,669 | 2026-07-28 |
Full buyer profile: what HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL buys and who wins it →
CPV codes
33652100 Medical equipment & pharmaceuticalsDescription
Adquisición del medicamento BREYANZI 1,1-70 x 10E6 Células/ML dispersión para perfusión (Lisocabtagen Maraleucel), para el Servicio de Farmacia del Hospital Universitario Ramón y Cajal.
Similar tenders
Closest by meaning — across languages, via embeddings.